Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Kalaris Therapeutics Inc., 3 years.
Kalaris Therapeutics Inc.
Director
Seer Inc.
Director
Scholar Rock Holding Corporation
Director · Chief Executive Officer
Chief executive roles
Scholar Rock Holding Corporation
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 16, 2026 | Scholar Rock Holding Corporation | Open-market sale | −30,615 | $49.57 | $1,517,586 |
| Feb 9, 2026 | Scholar Rock Holding Corporation | Grant or award | +128,004 | — | — |
| Jan 13, 2026 | Scholar Rock Holding Corporation | Open-market sale | −57,450 | $42.70 | $2,453,115 |
| Oct 8, 2025 | Scholar Rock Holding Corporation | Gift | −205,000 | — | — |
| Apr 27, 2025 | Scholar Rock Holding Corporation | Grant or award | +250,000 | — | — |
| Apr 27, 2025 | Scholar Rock Holding Corporation | Grant or award | +1,250,000 | — | — |
| Jun 27, 2024 | Scholar Rock Holding Corporation | Grant or award | +13,500 | — | — |
| Jun 12, 2024 | Seer Inc. | Grant or award | +58,178 | — | — |
| Jun 6, 2024 | Kalaris Therapeutics Inc. | Grant or award | +35,000 | — | — |
| Jun 14, 2023 | Seer Inc. | Grant or award | +23,443 | — | — |
| May 11, 2023 | Kalaris Therapeutics Inc. | Grant or award | +35,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.